Search
  • Dr.Mousa

COVID-19 Booster Vaccine Recommendation

Updated: Aug 24, 2021



08/24/2021


Dear Patients,

Dr. Mousa recommends our patients get the COVID-19 booster vaccine. We are currently following the CDC (Centers for Disease Control) and the ACR (American college of Rheumatology) guidelines. They are as follows.

· It is recommended that you receive the same manufacturer booster as the previous COVID-19 vaccine you received, if possible.

· The additional vaccine should be administered at least 28 days after completion of the primary vaccine series.

· If you are taking any Rheumatology medication other than Plaquenil or Sulfasalazine it is recommended to hold your medication for 1 week AFTER the booster vaccine. You do not need to hold it prior to the vaccine.


All immunocompromised patients should continue to follow prevention measures, including:

· Wearing a mask

· Staying 6 feet apart from those they don’t live with

· Avoiding crowds and poorly ventilated indoor spaces until advised otherwise by their healthcare provider

· Close contacts of immunocompromised people should be strongly encouraged to be vaccinated against COVID-19


We will continue to follow the CDC and ACR guidelines and will update patients accordingly.


Sincerely,


Arthritis & Rheumatology of Southwest Ohio

86 views0 comments

Recent Posts

See All

We recommend receiving both the influenza vaccine as well as the new covid-19 booster, just not together. The influenza vaccine should be administered at the end of October/ beginning of November. The

COVID19 Vaccine Information for Patients What vaccines are currently available in the United States? There are currently 2 vaccines for COVID19 that have received emergency use authorization (EUA) by

COVID Vaccine Ingredients There are two COVID-19 messenger-ribonucleic acid (mRNA) vaccines currently authorized for emergent use in the United States: the Pfizer-BioNTech and the Moderna vaccines. Co